Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients

Overview

The aim of our study was to compare the daily living activities with a performance-based protocol in lung cancer patients and healthy controls.

Full Title of Study: “Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 17, 2020

Detailed Description

Lung cancer is the abnormal proliferation of cells in the lung tissue and a mass in the lung. The primary symptoms of this health problem include cough, dyspnea, chest pain, hemoptysis and sputum. In addition to these symptoms, muscle strength, respiratory function and effort level are decreased. Inadequate daily living activities in cancer patients are expressed.But studies evaluating the activities of daily living in patients with lung cancer are inadequate and patients are evaluated only using scales. For the measurement of functional status in daily living activities, these scales provide important information about the detection of symptoms and the progression of the disease. However, it is very difficult to determine the limitation of perceived difficulty in daily living activities with these scales. In addition, since these scales are a method of measurement, the objectivity is open to discussion. It is thought that a performance-based protocol will facilitate the detection of limitations and provide more objective findings. We think that the Londrina protocol fully reflects the activities of daily living and thus will give us an objective measurement. This study will show us the problem and its cause in daily life activities in patients with lung cancer.

Arms, Groups and Cohorts

  • lung cancer
  • healthy control group

Clinical Trial Outcome Measures

Primary Measures

  • Activities Of Daily Living
    • Time Frame: 1st day
    • Daily Living Activities will be evaluated using the Londrina Protocol.The protocol consists of 5 stations. Stations are including organizing books on the table, 18 meters walking by carrying 10% of body weight symmetrically, arranging books by putting them on shelves, hanging the laundry in the laundry basket and walking 18 meters. İndividual will do these activities at his own pace and the time will be recorded at the end.

Secondary Measures

  • Life Quality
    • Time Frame: 1st Day
    • Quality of life will be measured using Core Quality of Life Questionnaire (EORTC QLQ-C30) The questionnaire consists of 30 questions and provides information on quality of life and symptoms.
  • Peripheral Muscle Strength
    • Time Frame: 1st Day
    • Muscle strength will be evaluated by force measuring dynamometer device 3 times. M.Quadriceps Femoris, shoulder abduction, shoulder flexion, elbow flexion, elbow extension and hand grip strength of all cases will be measured.
  • Dyspnoea
    • Time Frame: 1st Day
    • Dyspnoea will be evaluated using the Medical Research Council Dyspnoea Scale. The Medical Research Council Dyspnoea Scale has a score of 0-4. İn this scoring system 0 indicates that there is no dyspnoea, whereas 4 indicates that the dyspnoea is too high.
  • Respiratory Functions
    • Time Frame: 1st Day
    • Respiratory functions will be measured by spirometric measurement. This measurement will give us FEV1 FVC FEV1 / FVC values.
  • Exercise Capacity
    • Time Frame: 1st Day
    • 6 Minute walk test will be used.In the test, the person will be asked to walk as fast as possible in a 30-meter corridor and the walking distance will be recorded in 6 minutes.

Participating in This Clinical Trial

Inclusion Criteria

  • To have a diagnosis of lung cancer – Complete chemotherapy – Complete radiotherapy – Coopere, – Accepts participation in the study will be included in the study Exclusion Criteria:

  • Neurological, cognitive or orthopedic diseases that affect the measurements – Acute infection – Individuals with other chronic diseases that may affect their walking will not be included in the study

Gender Eligibility: All

Minimum Age: 30 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hacettepe University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Hamide Sahin, Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients – Hacettepe University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.